TWI327917B - - Google Patents

Download PDF

Info

Publication number
TWI327917B
TWI327917B TW91101827A TW91101827A TWI327917B TW I327917 B TWI327917 B TW I327917B TW 91101827 A TW91101827 A TW 91101827A TW 91101827 A TW91101827 A TW 91101827A TW I327917 B TWI327917 B TW I327917B
Authority
TW
Taiwan
Prior art keywords
trap
ets
mmp
nucleic acid
doc
Prior art date
Application number
TW91101827A
Other languages
English (en)
Chinese (zh)
Inventor
Ryuichi Morishita
Aoki Motokuni
Kawasaki Tomio
Original Assignee
Anges Mg Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anges Mg Inc filed Critical Anges Mg Inc
Priority to TW91101827A priority Critical patent/TWI327917B/zh
Application granted granted Critical
Publication of TWI327917B publication Critical patent/TWI327917B/zh

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TW91101827A 2002-02-01 2002-02-01 TWI327917B (enExample)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW91101827A TWI327917B (enExample) 2002-02-01 2002-02-01

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW91101827A TWI327917B (enExample) 2002-02-01 2002-02-01

Publications (1)

Publication Number Publication Date
TWI327917B true TWI327917B (enExample) 2010-08-01

Family

ID=46551295

Family Applications (1)

Application Number Title Priority Date Filing Date
TW91101827A TWI327917B (enExample) 2002-02-01 2002-02-01

Country Status (1)

Country Link
TW (1) TWI327917B (enExample)

Similar Documents

Publication Publication Date Title
US8067388B2 (en) Decoy-containing pharmaceutical compositions and method of using the same
JP2009102428A (ja) デコイを含む薬学的組成物およびその使用方法
US20130280205A1 (en) Activators of SGK-1 for Use as Cardioprotective Agents
JP6124986B2 (ja) 拡張期心不全を処置するための増殖分化因子（ｇｄｆ）
RU2637372C2 (ru) Средство для лечения фиброза кишечника
RU2711531C2 (ru) Средство для лечения фиброза почек
JP6571069B2 (ja) 環状アデノシン一リン酸−インコンピテントアデニリルシクラーゼならびに心不全を処置するおよび心機能を増大させるための組成物および方法
Ding et al. ROS-responsive microneedles loaded with integrin avβ6-blocking antibodies for the treatment of pulmonary fibrosis
Nakamura et al. Lipid nanoparticles fuse with cell membranes of immune cells at low temperatures leading to the loss of transfection activity
Tao et al. A nano-platform combats the “attack” and “defense” of cytoskeleton to block cascading tumor metastasis
JPWO2003082331A1 (ja) 脳疾患および障害を処置および予防するためのデコイ組成物
JP4346233B2 (ja) デコイを含む薬学的組成物およびその使用方法
JP2019182873A (ja) 膵臓炎、腎損傷および腎臓癌を治療および予防するための組成物および方法
JP2002193813A5 (enExample)
KR102785286B1 (ko) 특발성 폐 섬유증의 약물 표적
EP4431085A1 (en) Lipid composition and substance delivery method
US10751324B2 (en) Treatment of TNF- alpha cytotoxicity
JP5057587B2 (ja) デコイを含む薬学的組成物およびその使用方法
US12440497B2 (en) Compositions and methods for enhancing Wnt signaling for treating cancer
JP4305857B2 (ja) デコイを含む薬学的組成物およびその使用方法
Yuan et al. Molecular Mechanisms of Myocardial Repair and Cardiac Function Improvement With Hydrogel‐Mediated Macrophage‐Derived Exosome Delivery
JP3908776B2 (ja) 細胞への遺伝子導入用組成物
TW202317115A (zh) 組成物用於治療高血壓的用途
JP2025519230A (ja) 梗塞進展の処置および予防に使用するｓ１００ａ１タンパク質
Song et al. STAT1 as a downstream mediator of ERK signaling contributes to bone cancer pain by

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees